Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor α allele in the prostate epithelium

Jiapeng Huang, William C. Powell, Ani C. Khodavirdi, Jian Wu, Takako Makita, Robert Cardiff, Michael B. Cohen, Henry M. Sucov, Pradip Roy-Burman

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Retinoids, which are important regulators of cell growth, differentiation, and apoptosis, have been used in treatment or chemoprevention of multiple cancers including prostate cancer. To elucidate the mechanism of action of retinoids in the context of the prostate, we used the Cre-loxP system to disrupt the retinoid X receptor a (RXRα) gene specifically in the prostatic epithelium of the mouse. Evidence for tissue-specific gene inactivation was obtained at DNA, RNA, and protein levels. Phenotypic changes in the prostate in the homozygous animals of different age groups ranging from 1 to 15 months were investigated. Developmentally, prostatic ductal branching appeared to be increased from the loss of RXRα function. There was also a significant change in the profile of secretory proteins in the RXRα mutant prostate relative to littermate controls with intact RXRα allele. Histopathologically, homozygous RXRα-deficient prostates showed multifocal hyperplasia as early as 4 months of age. Lesions, which could be described as low-grade prostatic intraepithelial neoplasias, were detected after 5 months. Subsequently, beginning at ∼10 months, high-grade prostatic intraepithelial neoplasias developed in some animals. The incidences of low-grade prostatic intraepithelial neoplasias and high-grade prostatic intraepithelial neoplasias among the animals 10-15 months of age were 62 and 17%, respectively. The heterozygous mutant mice also developed similar prostatic phenotypes but in a delayed manner, implying a role of haploinsufficiency. Together, these results indicated for the first time that a major component of retinoid action in the prostate is mediated by a retinoid receptor, RXRα, the inactivation of which in the prostatic epithelium leads to the development of preneoplastic lesions.

Original languageEnglish (US)
Pages (from-to)4812-4819
Number of pages8
JournalCancer Research
Volume62
Issue number16
StatePublished - Aug 15 2002

Fingerprint

Prostatic Intraepithelial Neoplasia
Retinoid X Receptors
Prostate
Epithelium
Alleles
Retinoids
Prostatic Neoplasms
Haploinsufficiency
Chemoprevention
Gene Silencing
Hyperplasia
Cell Differentiation
Proteins
Age Groups
RNA
Apoptosis
Phenotype
DNA
Incidence
Growth

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Huang, J., Powell, W. C., Khodavirdi, A. C., Wu, J., Makita, T., Cardiff, R., ... Roy-Burman, P. (2002). Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor α allele in the prostate epithelium. Cancer Research, 62(16), 4812-4819.

Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor α allele in the prostate epithelium. / Huang, Jiapeng; Powell, William C.; Khodavirdi, Ani C.; Wu, Jian; Makita, Takako; Cardiff, Robert; Cohen, Michael B.; Sucov, Henry M.; Roy-Burman, Pradip.

In: Cancer Research, Vol. 62, No. 16, 15.08.2002, p. 4812-4819.

Research output: Contribution to journalArticle

Huang, J, Powell, WC, Khodavirdi, AC, Wu, J, Makita, T, Cardiff, R, Cohen, MB, Sucov, HM & Roy-Burman, P 2002, 'Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor α allele in the prostate epithelium', Cancer Research, vol. 62, no. 16, pp. 4812-4819.
Huang, Jiapeng ; Powell, William C. ; Khodavirdi, Ani C. ; Wu, Jian ; Makita, Takako ; Cardiff, Robert ; Cohen, Michael B. ; Sucov, Henry M. ; Roy-Burman, Pradip. / Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor α allele in the prostate epithelium. In: Cancer Research. 2002 ; Vol. 62, No. 16. pp. 4812-4819.
@article{a190fc7c2ebd4dc8bd4ad9519391944a,
title = "Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor α allele in the prostate epithelium",
abstract = "Retinoids, which are important regulators of cell growth, differentiation, and apoptosis, have been used in treatment or chemoprevention of multiple cancers including prostate cancer. To elucidate the mechanism of action of retinoids in the context of the prostate, we used the Cre-loxP system to disrupt the retinoid X receptor a (RXRα) gene specifically in the prostatic epithelium of the mouse. Evidence for tissue-specific gene inactivation was obtained at DNA, RNA, and protein levels. Phenotypic changes in the prostate in the homozygous animals of different age groups ranging from 1 to 15 months were investigated. Developmentally, prostatic ductal branching appeared to be increased from the loss of RXRα function. There was also a significant change in the profile of secretory proteins in the RXRα mutant prostate relative to littermate controls with intact RXRα allele. Histopathologically, homozygous RXRα-deficient prostates showed multifocal hyperplasia as early as 4 months of age. Lesions, which could be described as low-grade prostatic intraepithelial neoplasias, were detected after 5 months. Subsequently, beginning at ∼10 months, high-grade prostatic intraepithelial neoplasias developed in some animals. The incidences of low-grade prostatic intraepithelial neoplasias and high-grade prostatic intraepithelial neoplasias among the animals 10-15 months of age were 62 and 17{\%}, respectively. The heterozygous mutant mice also developed similar prostatic phenotypes but in a delayed manner, implying a role of haploinsufficiency. Together, these results indicated for the first time that a major component of retinoid action in the prostate is mediated by a retinoid receptor, RXRα, the inactivation of which in the prostatic epithelium leads to the development of preneoplastic lesions.",
author = "Jiapeng Huang and Powell, {William C.} and Khodavirdi, {Ani C.} and Jian Wu and Takako Makita and Robert Cardiff and Cohen, {Michael B.} and Sucov, {Henry M.} and Pradip Roy-Burman",
year = "2002",
month = "8",
day = "15",
language = "English (US)",
volume = "62",
pages = "4812--4819",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor α allele in the prostate epithelium

AU - Huang, Jiapeng

AU - Powell, William C.

AU - Khodavirdi, Ani C.

AU - Wu, Jian

AU - Makita, Takako

AU - Cardiff, Robert

AU - Cohen, Michael B.

AU - Sucov, Henry M.

AU - Roy-Burman, Pradip

PY - 2002/8/15

Y1 - 2002/8/15

N2 - Retinoids, which are important regulators of cell growth, differentiation, and apoptosis, have been used in treatment or chemoprevention of multiple cancers including prostate cancer. To elucidate the mechanism of action of retinoids in the context of the prostate, we used the Cre-loxP system to disrupt the retinoid X receptor a (RXRα) gene specifically in the prostatic epithelium of the mouse. Evidence for tissue-specific gene inactivation was obtained at DNA, RNA, and protein levels. Phenotypic changes in the prostate in the homozygous animals of different age groups ranging from 1 to 15 months were investigated. Developmentally, prostatic ductal branching appeared to be increased from the loss of RXRα function. There was also a significant change in the profile of secretory proteins in the RXRα mutant prostate relative to littermate controls with intact RXRα allele. Histopathologically, homozygous RXRα-deficient prostates showed multifocal hyperplasia as early as 4 months of age. Lesions, which could be described as low-grade prostatic intraepithelial neoplasias, were detected after 5 months. Subsequently, beginning at ∼10 months, high-grade prostatic intraepithelial neoplasias developed in some animals. The incidences of low-grade prostatic intraepithelial neoplasias and high-grade prostatic intraepithelial neoplasias among the animals 10-15 months of age were 62 and 17%, respectively. The heterozygous mutant mice also developed similar prostatic phenotypes but in a delayed manner, implying a role of haploinsufficiency. Together, these results indicated for the first time that a major component of retinoid action in the prostate is mediated by a retinoid receptor, RXRα, the inactivation of which in the prostatic epithelium leads to the development of preneoplastic lesions.

AB - Retinoids, which are important regulators of cell growth, differentiation, and apoptosis, have been used in treatment or chemoprevention of multiple cancers including prostate cancer. To elucidate the mechanism of action of retinoids in the context of the prostate, we used the Cre-loxP system to disrupt the retinoid X receptor a (RXRα) gene specifically in the prostatic epithelium of the mouse. Evidence for tissue-specific gene inactivation was obtained at DNA, RNA, and protein levels. Phenotypic changes in the prostate in the homozygous animals of different age groups ranging from 1 to 15 months were investigated. Developmentally, prostatic ductal branching appeared to be increased from the loss of RXRα function. There was also a significant change in the profile of secretory proteins in the RXRα mutant prostate relative to littermate controls with intact RXRα allele. Histopathologically, homozygous RXRα-deficient prostates showed multifocal hyperplasia as early as 4 months of age. Lesions, which could be described as low-grade prostatic intraepithelial neoplasias, were detected after 5 months. Subsequently, beginning at ∼10 months, high-grade prostatic intraepithelial neoplasias developed in some animals. The incidences of low-grade prostatic intraepithelial neoplasias and high-grade prostatic intraepithelial neoplasias among the animals 10-15 months of age were 62 and 17%, respectively. The heterozygous mutant mice also developed similar prostatic phenotypes but in a delayed manner, implying a role of haploinsufficiency. Together, these results indicated for the first time that a major component of retinoid action in the prostate is mediated by a retinoid receptor, RXRα, the inactivation of which in the prostatic epithelium leads to the development of preneoplastic lesions.

UR - http://www.scopus.com/inward/record.url?scp=0037102446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037102446&partnerID=8YFLogxK

M3 - Article

C2 - 12183441

AN - SCOPUS:0037102446

VL - 62

SP - 4812

EP - 4819

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 16

ER -